Anti-Bub3 antibody
| Name | Anti-Bub3 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab4180 |
| Prices | $392.00 |
| Sizes | 100 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | WB EMSA |
| Species Reactivities | Human, Mouse, Rat, Xenopus, Zebrafish |
| Antigen | Synthetic peptide derived from residues 300 to the C-terminus of Human Bub3 |
| Description | Rabbit Polyclonal |
| Gene | BUB3 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Anti-Bub3 antibody (ab4180) at 1/500 dilution + HeLa Nuclear Extract at 20 µgSecondaryGoat Anti-Rabbit IgG H&L (HRP) (ab6721) at 1/2000 dilution
Product References
Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in - Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in
Burns SS, Akhmametyeva EM, Oblinger JL, Bush ML, Huang J, Senner V, Chen CS, Jacob A, Welling DB, Chang LS. Cancer Res. 2013 Jan 15;73(2):792-803.
CPEB1 coordinates alternative 3'-UTR formation with translational regulation. - CPEB1 coordinates alternative 3'-UTR formation with translational regulation.
Bava FA, Eliscovich C, Ferreira PG, Minana B, Ben-Dov C, Guigo R, Valcarcel J, Mendez R. Nature. 2013 Mar 7;495(7439):121-5.
Identification of CTCF as a master regulator of the clustered protocadherin - Identification of CTCF as a master regulator of the clustered protocadherin
Golan-Mashiach M, Grunspan M, Emmanuel R, Gibbs-Bar L, Dikstein R, Shapiro E. Nucleic Acids Res. 2012 Apr;40(8):3378-91.
Evidence that mitotic exit is a better cancer therapeutic target than spindle - Evidence that mitotic exit is a better cancer therapeutic target than spindle
Huang HC, Shi J, Orth JD, Mitchison TJ. Cancer Cell. 2009 Oct 6;16(4):347-58.